SERPINE1 and fatty liver disease: PAI-1, an inflammatory adipokine and a recognized biomarker of metabolic syndrome [40,41], is closely associated with cardiovascular disease, hepatic steatosis, dyslipidemia, and adipose tissue dysfunction [42,43,44].